Shuttle Pharmaceuticals (SHPH) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Shuttle Pharmaceuticals Revenue Highlights


00

Shuttle Pharmaceuticals Revenue by Period


Shuttle Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--

Shuttle Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Shuttle Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$9.66K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--

Shuttle Pharmaceuticals generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Shuttle Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CTLTCatalent$4.28B$1.07B
TLRYTilray Brands$788.94M$188.34M
ORGOOrganogenesis$433.14M$130.23M
LFCRLifecore Biomedical$128.26M$35.70M
ALIMAlimera Sciences$80.75M$23.01M
DERMJourney Medical$79.18M$14.86M
AGRXAgile Therapeutics$19.59M$5.58M
AKANAkanda$2.16M$762.61K
LSDILucy Scientific Discovery$7.05K$9.68K
SHPHShuttle Pharmaceuticals--

SHPH Revenue FAQ


Shuttle Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. SHPH's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Shuttle Pharmaceuticals's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $9.66K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). SHPH's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

Shuttle Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%